Prospective Randomized Group Controlled Study of Clinical Efficacy and Safety of the CE marked Vivira App In-Home Therapeutic Training Program”

Not Applicable

• Conditions: Other indications: M99.02, M99.03, M99.04, M99.82, M99.83, M99.84, M99.92, M99.93, M99.94, M42.0, M42.9, M54.4; M42.1; M54.9; M53.2; M53.8; M53.9; M54.5; M54.6; M54.8; Adult osteochondrosis of spine

• Registration Number: DRKS00022781
• Lead Sponsor: Facharztpraxis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-11-02
• Study Completion: 2021-03-31
• Results First Posted: 2022-10-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 213

Inclusion Criteria

Adult patients with back/spinal pain; baseline pain score of 4 or more

Exclusion Criteria

Serious internal, neurological, vision, spine or bone disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain reduction measured by VNRS after 2, 6 and 12 weeks

Secondary Outcome Measures

Name	Time	Method
Function improvement of mobility